<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36146806</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Follow-Up of a Cohort of Patients with Post-Acute COVID-19 Syndrome in a Belgian Family Practice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2000</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14092000</ELocationID><Abstract><AbstractText>Fifty-five patients who suffered from COVID-19, who were still very ill after several months, with extreme fatigue, effort exhaustion, brain fog, anomia, memory disorder, anosmia, dysgeusia, and other multi-systemic health problems have been followed in a family practice setting between May 2021 and July 2022. Data extracted from the medical records of the 55 patients (40 women), mean age 42.4 (12 to 79 years), and a qualitative study of 6 of them using a semi-open-ended questionnaire allowed to highlight the clinical picture described by WHO as post-acute COVID-19 syndrome (PACS) also known as long COVID. We used brain single-photon emission computed tomography (SPECT-CT) in thirty-two patients with a high severity index and a highly impaired functional status, demonstrating vascular encephalopathy in twenty nine patients and supporting the hypothesis of a persistent cerebral vascular flow disorder in post COVID-19 condition. The patients will benefit from the consortium COVID Human Genetic Effort (covidhge.com) to explore the genetic and immunological basis of their problem, as 23/55 cases don't have immunological certainty of a COVID-19 infection. There is no known verified treatment. Analyzing the data from the first 52 patients, three categories of patients emerged over time: 16 patients made a full recovery after 6-8 months, 15 patients were able to return to life and work after 12-18 months with some sequelae, both groups being considered cured. In the third group, 21 patients are still very ill and unable to resume their work and life after 18 months. The biopsychosocial consequences on patients' lives are severe and family doctors are left out in the cold. It is necessary to test the reproducibility of this description, conducted on a small number of patients. Nevertheless, identifying, monitoring and supporting these patients is a necessity in family medicine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jamoulle</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0479-3856</Identifier><AffiliationInfo><Affiliation>HEC Information Sciences, University of Li&#xe8;ge, 4000 Liege, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazeneza-Mugisha</LastName><ForeName>Gisele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Mons, 7000 Mons, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayane</LastName><ForeName>Ayoub</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre Medical Janson, 6000 Charleroi, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005194" MajorTopicYN="N">Family Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">encephalopathy</Keyword><Keyword MajorTopicYN="N">general practice</Keyword><Keyword MajorTopicYN="N">health status indicator</Keyword><Keyword MajorTopicYN="N">medically unexplained symptoms</Keyword><Keyword MajorTopicYN="N">narrative medicine</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">single photon emission computed tomography (SPEC CT scan)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36146806</ArticleId><ArticleId IdType="pmc">PMC9505954</ArticleId><ArticleId IdType="doi">10.3390/v14092000</ArticleId><ArticleId IdType="pii">v14092000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blomberg B., Mohn K.G.I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou G.N., Baraff A., Fox A., Shahoumian T., Hickok A., O&#x2019;Hare A.M., Bohnert A.S.B., Boyko E.J., Maciejewski M.L., Bowling C.B., et al. Rates and Factors Associated with Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System. JAMA Netw. Open. 2022;5:e2224359. doi: 10.1001/jamanetworkopen.2022.24359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.24359</ArticleId><ArticleId IdType="pmc">PMC9338411</ArticleId><ArticleId IdType="pubmed">35904783</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Abou Shaar B., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: What do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370 doi: 10.1136/bmj.m2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgers J. &#x201c;Long covid&#x201d;: The Dutch response. BMJ. 2020;370 doi: 10.1136/bmj.m3202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3202</ArticleId><ArticleId IdType="pubmed">32816711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando H.M., Bennett T.D., Byrd J.B., Bramante C., Callahan T.J., Chute C.G., Davis H.E., Deer R., Gagnier J., Koraishy F.M., et al. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. 2021 doi: 10.1101/2021.03.20.21253896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. 6 October 2021.  [(accessed on 7 July 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Munro M. Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK. 7 July 2022.  [(accessed on 7 July 2022)].  Available online:  https://tinyurl.com/long-covid-uk.</Citation></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:1494. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P., Casari G., Townsend L., O&#x2019;Farrelly C., Tancevski I., L&#xf6;ffler-Ragg J., Mogensen T.H., Casanova J.L. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 2022;28:879&#x2013;882. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K., Olde Hartman T.C., Rosmalen J.G., Initiative L.C.R. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370 doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., Stone K., Navis A., Festa J.R., Wisnivesky J.P. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2021 doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Wirtheim E., Vetter P., Kalil A.C., Bruchfeld J., Runold M., Guaraldi G., Mussini C., Gudiol C., Pujol M., et al. Long-term consequences of COVID-19: Research needs. Lancet Infect. Dis. 2020;20:1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A., Soret M., Pyatigoskaya N., Habert M.O., Hesters A., Le Guennec L., Paccoud O., Bombois S., Delorme C. The cerebral network of COVID-19-related encephalopathy: A longitudinal voxel-based 18F-FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:1&#x2013;15. doi: 10.1007/s00259-020-05178-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05178-y</ArticleId><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N., Le Guen M., Russel S., Touche P., Huang F., Vall&#xe9;e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci. Rep. 2021;11:1&#x2013;7. doi: 10.1038/s41598-021-93546-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel S.A., Olde Hartman T.C., Lucassen P.L., van Jaarsveld C.H. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022 doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Godeau D., Petit A., Richard I., Roquelaure Y., Descatha A. Return-to-work, disabilities and occupational health in the age of COVID-19. Scand. J. Work. Environ. Health. 2021 doi: 10.5271/sjweh.3960.</Citation><ArticleIdList><ArticleId IdType="doi">10.5271/sjweh.3960</ArticleId><ArticleId IdType="pmc">PMC8259700</ArticleId><ArticleId IdType="pubmed">34003294</ArticleId></ArticleIdList></Reference><Reference><Citation>Messin L., Puyraveau M., Benabdallah Y., Lepiller Q., Gendrin V., Zayet S., Klopfenstein T., Toko L., Pierron A., Royer P.Y. COVEVOL: Natural Evolution at 6 Months of COVID-19. Viruses. 2021;13:2151. doi: 10.3390/v13112151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112151</ArticleId><ArticleId IdType="pmc">PMC8619893</ArticleId><ArticleId IdType="pubmed">34834958</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Long COVID: Pathophysiology-Epidemiology and Patient Needs. KCE, Belgium.  [(accessed on 7 July 2022)]; Available online:  https://kce.fgov.be/sites/default/files/atoms/files/2020-04HSR_Long%20COVID_Scientifi.</Citation></Reference><Reference><Citation>Ledford H. Do vaccines protect against long COVID? What the data say. Nature. 2021;599:546&#x2013;548. doi: 10.1038/d41586-021-03495-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03495-2</ArticleId><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO-News  A Life Altered by Long COVID&#x2014;Susan&#x2019;s Experience.  [(accessed on 7 July 2022)].  Available online:  https://www.who.int/europe/news/item/09-08-2022-a-life-altered-by-long-covid&#x2014;susan-s-experience.</Citation></Reference><Reference><Citation>Aghaei A., Zhang R., Taylor S., Tam C.C., Yang C.H., Li X., Qiao S. Impact of COVID-19 symptoms on social aspects of life among female long haulers: A qualitative study. Res. Sq. 2022;rs.3.rs:1285284. doi: 10.21203/rs.3.rs-1285284/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1285284/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Vyver J., Leite A.C., Alwan N.A. Navigating the social identity of long covid. BMJ. 2021;375:n2933. doi: 10.1136/bmj.n2933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2933</ArticleId><ArticleId IdType="pubmed">34836878</ArticleId></ArticleIdList></Reference><Reference><Citation>Runco M.A., Chand Y. Problem Finding, Problem Solving, and Creativity. Ablex Publishing; New York, NY, USA: 1974. Problem Finding, Evaluative Thinking, and Creativity; pp. 40&#x2013;47. Book Section 2.</Citation></Reference><Reference><Citation>Dirkzwager A.J., Verhaak P.F. Patients with persistent medically unexplained symptoms in general practice: Characteristics and quality of care. BMC Fam. Pract. 2007;8:1&#x2013;10. doi: 10.1186/1471-2296-8-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2296-8-33</ArticleId><ArticleId IdType="pmc">PMC1894968</ArticleId><ArticleId IdType="pubmed">17540013</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T. Narrative based medicine in an evidence based world. BMJ. 1999;318:323&#x2013;325. doi: 10.1136/bmj.318.7179.323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.318.7179.323</ArticleId><ArticleId IdType="pmc">PMC1114786</ArticleId><ArticleId IdType="pubmed">9924065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood M. Naming the illness: The power of words. Fam. Med. 1991;23:534&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">1936736</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnik D.B. Glossary of Commonly Used Terms in Research Ethics.  [(accessed on 24 August 2022)]; Available online:  https://www.niehs.nih.gov/research/resources/bioethics/glossary/index.cfm.</Citation></Reference><Reference><Citation>Bentzen N. WONCA Dictionary of General/Family Practice. 2004.  [(accessed on 1 September 2022)].  Available online:  http://www.ph3c.org/PH3C/docs/27/000092/0000052.pdf.</Citation></Reference><Reference><Citation>Jamoulle M., Kazeneza-Mugisha G. Descriptive and Narrative Study of Long Covid Cases in General Practice and Diagnostic Value of Single Photon Emission Computed Tomography. medRxiv. 2022 doi: 10.1101/2022.03.01.22270897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.01.22270897</ArticleId></ArticleIdList></Reference><Reference><Citation>Okkes I., Jamoulle M., Lamberts H., Bentzen N. ICPC-2-E: The electronic version of ICPC-2. Differences from the printed version and the consequences. Fam. Pract. 2000;17:101&#x2013;107. doi: 10.1093/fampra/17.2.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/17.2.101</ArticleId><ArticleId IdType="pubmed">10758069</ArticleId></ArticleIdList></Reference><Reference><Citation>Llewelyn H. Reasoning in Medicine and Science. 2013.  [(accessed on 7 July 2022)].  Available online:  https://blog.oup.com/2013/09/medical-diagnosis-reasoning-probable-elimination.</Citation></Reference><Reference><Citation>Parkerson G.R., Jr., Broadhead W.E., Chiu-Kit J. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J. Clin. Epidemiol. 1993;46:379&#x2013;393. doi: 10.1016/0895-4356(93)90153-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(93)90153-R</ArticleId><ArticleId IdType="pubmed">8483003</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkerson G., Jr. Description of the DUSOI-WONCA Severity of Illness Instrument. 1999.  [(accessed on 7 July 2022)].  Available online:  http://www.ph3c.org/4daction/w3_CatVisu/en/description-of-the-dusoi&#x2014;-wonca&#x2013;severity-of-illness-instrument.html?wDocID=157.</Citation></Reference><Reference><Citation>Jamoulle M., Roland M., Elkinne J., Parkerson G. Le DUSOI/WONCA un indice de gravit&#xe9; pour la m&#xe9;decine g&#xe9;n&#xe9;rale. 2000.  [(accessed on 7 July 2022)].  Available online:  https://orbi.uliege.be/handle/2268/228936.</Citation></Reference><Reference><Citation>van Weel C., K&#xf6;nig Zahn C., Touw Otten F., van Duijn N., Meyboom de Jong B. Measuring Functional Health Status with the COOP/WONCA Charts. A Manual. 1995.  [(accessed on 7 July 2022)].  Available online:  http://www.ph3c.org/PH3C/docs/27/000150/0000103.pdf.</Citation></Reference><Reference><Citation>Casanova J.L., Su H.C., Abel L., Aiuti A., Almuhsen S., Arias A.A., Bastard P., Biggs C., Bogunovic D., Boisson B., et al. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. 2020;181:1194&#x2013;1199. doi: 10.1016/j.cell.2020.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.016</ArticleId><ArticleId IdType="pmc">PMC7218368</ArticleId><ArticleId IdType="pubmed">32405102</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Million M., Dudouet P., Tissot-Dupont H., Bregeon F., Cammilleri S., Raoult D. 18 F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: Substrate for persistent/delayed disorders? Eur. J. Nucl. Med. Mol. Imaging. 2021;48:592&#x2013;595. doi: 10.1007/s00259-020-04973-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Lazarini F., Morbelli S., Ceccaldi M., Hautefort C., Kas A., Radulesco T., Salmon-Ceron D., Eldin C. Long COVID and the brain network of Proust&#x2019;s madeleine: Targeting the olfactory pathway. Clin. Microbiol. Infect. 2021 doi: 10.1016/j.cmi.2021.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.015</ArticleId><ArticleId IdType="pmc">PMC8164472</ArticleId><ArticleId IdType="pubmed">34015528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Alfonso B., Sol&#xed;s S.R., Silva-Hern&#xe1;ndez L., Pascual I.P., Ib&#xe1;&#xf1;ez S.A., Ant&#xf3;n C.S. 18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae. Rev. Esp. Med. Nucl. Imagen Mol. 2021 doi: 10.1016/j.remnie.2021.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.remnie.2021.07.005</ArticleId><ArticleId IdType="pmc">PMC8316133</ArticleId><ArticleId IdType="pubmed">34340958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-covid: Cognitive deficits (brain fog) and brain lesions in non-hospitalized patients. Presse Med. 2021 doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A., Kas A., Dudouet P., Goehringer F., Salmon D., Guedj E. Visual Interpretation of Brain Hypometabolisms Related to Neurological Long COVID: A French Multicentric Experience. Eur. J. Nucl. Med. Mol. Imaging. 2022;32 doi: 10.1007/s00259-022-05753-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05753-5</ArticleId><ArticleId IdType="pmc">PMC8941296</ArticleId><ArticleId IdType="pubmed">35320385</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnemiller E., Heilmann J., Wenning G.K., Berger W., Decristoforo C., Moncayo R., Poewe W., Ransmayr G. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta -CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur. J. Nucl. Med. 2021;24:320&#x2013;325. doi: 10.1007/BF01728771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01728771</ArticleId><ArticleId IdType="pubmed">9143472</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepstone B.J. Cerebral scintigraphy&#x2013;the phoenix rises again. Postgrad. Med. J. 1988;64:4&#x2013;17. doi: 10.1136/pgmj.64.747.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.64.747.4</ArticleId><ArticleId IdType="pmc">PMC2428734</ArticleId><ArticleId IdType="pubmed">3047720</ArticleId></ArticleIdList></Reference><Reference><Citation>Catafau A.M. Brain SPECT in clinical practice. Part I: Perfusion. J. Nucl. Med. 2001;42:259&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">11216525</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama M., Kawashima R., Ito H., Ono S., Sato K., Goto R., Kinomura S., Yoshioka S., Sato T., Fukuda H. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J. Nucl. Med. 1997;38:587&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pubmed">9098207</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., von Bartheld C.S. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist. 2020;27:582&#x2013;603. doi: 10.1177/1073858420956905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420956905</ArticleId><ArticleId IdType="pmc">PMC7488171</ArticleId><ArticleId IdType="pubmed">32914699</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin J., Frosch M.P., Mukerji S.S., Rapalino O., Maher M.D., Schaefer P.W., Lev M.H., Gonzalez R., Das S., Champion S.N., et al. Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J. Neurol. Sci. 2021;421:117308. doi: 10.1016/j.jns.2021.117308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117308</ArticleId><ArticleId IdType="pmc">PMC7832284</ArticleId><ArticleId IdType="pubmed">33497950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., Merdji H., Schenck M., Oesterl&#xe9; H., Bolognini F., Messie J., Khalil A., Gaudemer A., et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020;95:e1868&#x2013;e1882. doi: 10.1212/WNL.0000000000010112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010112</ArticleId><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamal S.M.T., Azab A.O.M., El Refaei S.M., Houseni M. The role of 18-FDG PET/CT assessment of functional brain metabolism in cancer patients after chemotherapy. Egypt. J. Radiol. Nucl. Med. 2021;52:1&#x2013;7. doi: 10.1186/s43055-020-00403-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00403-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison C.M., O&#x2019;Brien J.T. A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: A systematic review. Int. J. Geriatr. Psychiatry. 2014;29:551&#x2013;561. doi: 10.1002/gps.4036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4036</ArticleId><ArticleId IdType="pubmed">24123413</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G., Schr&#xf6;ter N., Bormann T., Thurow J., Wagner D., Frings L., Weiller C., Meyer P.T., Dressing A., Hosp J.A. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J. Nucl. Med. 2021 doi: 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon O.C., Carey A., Creed A., Durcan S., Blake C. Reliability and validity of COOP/WONCA functional health status charts for stroke patients in primary care. J. Stroke Cerebrovasc. Dis. 2011;20:465&#x2013;473. doi: 10.1016/j.jstrokecerebrovasdis.2010.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2010.02.020</ArticleId><ArticleId IdType="pubmed">20813545</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G.J., Barco S., Endres M., Geelhoed J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual. Life Outcomes. 2021;19:1&#x2013;11. doi: 10.1186/s12955-021-01862-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01862-1</ArticleId><ArticleId IdType="pmc">PMC8477362</ArticleId><ArticleId IdType="pubmed">34583690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., Wallace E. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147&#x2013;153. doi: 10.1016/0022-3999(93)90081-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackett D.L., Rosenberg W.M., Gray J.M., Haynes R.B., Richardson W.S. Evidence based medicine: What it is and what it isn&#x2019;t. Br. Med. J. 1996;312 doi: 10.1136/bmj.312.7023.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.312.7023.71</ArticleId><ArticleId IdType="pmc">PMC2349778</ArticleId><ArticleId IdType="pubmed">8555924</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger J.P., Morales I., De Paepe P. Medical heuristics and action-research: Professionalism versus science. BMC Health Serv. Res. 2020;20:1&#x2013;9. doi: 10.1186/s12913-020-05888-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05888-x</ArticleId><ArticleId IdType="pmc">PMC7724783</ArticleId><ArticleId IdType="pubmed">33292206</ArticleId></ArticleIdList></Reference><Reference><Citation>Pols J. Knowing patients: Turning patient knowledge into science. Sci. Technol. Hum. Values. 2014;39:73&#x2013;97. doi: 10.1177/0162243913504306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0162243913504306</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhinney I. Problem-solving &amp; decision-making in family practice. Can. Fam. Physician. 1979;25:1473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2383247</ArticleId><ArticleId IdType="pubmed">20469304</ArticleId></ArticleIdList></Reference><Reference><Citation>Malterud K. The art and science of clinical knowledge: Evidence beyond measures and numbers. Lancet. 2001;358:397&#x2013;400. doi: 10.1016/S0140-6736(01)05548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)05548-9</ArticleId><ArticleId IdType="pubmed">11502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Environmental Protection Agency  Radionuclide Basics: Technetium-99.  [(accessed on 7 July 2022)];2021  Available online:  https://www.epa.gov/radiation/radionuclide-basics-technetium-99.</Citation></Reference><Reference><Citation>Vucina J. Technetium-99m production for use in nuclear medicine. Med. Pregl. 2000;53:631:4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11320753</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines A., Scheelbeek P., Abbasi K. Challenges for health in the Anthropocene epoch. BMJ. 2019;364:1460. doi: 10.1136/bmj.l460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l460</ArticleId><ArticleId IdType="pmc">PMC7616371</ArticleId><ArticleId IdType="pubmed">30718363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Renteria H., Travieso A., Sagir A., Mart&#xed;nez-G&#xf3;mez E., Carrascosa-Granada A., Toya T., N&#xfa;&#xf1;ez-Gil I.J., Estrada V., Lerman A., Escaned J. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int. J. Cardiol. 2021;345:153&#x2013;155. doi: 10.1016/j.ijcard.2021.10.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.10.140</ArticleId><ArticleId IdType="pmc">PMC8542397</ArticleId><ArticleId IdType="pubmed">34706286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Harrer T., Mardin C., Kruse F., Hoffmanns J., Rogge L., Heltmann F., Moritz M., Szewczykowski C., Schottenhamml J., et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front. Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;Sullivan J.M., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter C., Bezuidenhout J.A., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. Erythrocyte, platelet, serum ferritin, and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int. J. Mol. Sci. 2020;21:8234. doi: 10.3390/ijms21218234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin (ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:1&#x2013;18. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones O.Y., Yeralan S. Is Long COVID a State of Systemic Pericyte Disarray? J. Clin. Med. 2022;11:572. doi: 10.3390/jcm11030572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030572</ArticleId><ArticleId IdType="pmc">PMC8836446</ArticleId><ArticleId IdType="pubmed">35160024</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I., Mayer M.G., Hellmers L.M., Ning B., Huang Z., Monjure C.J., Coyne C., Silvestri R., Golden N., Hensley K., et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun. 2022;13:1&#x2013;13. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon D.E., Gallman A.E., Hruza G.J., Rosenbach M., Lipoff J.B., Desai S.R., French L.E., Lim H., Cyster J.G., Fox L.P., et al. Long COVID in the skin: A registry analysis of COVID-19 dermatological duration. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(20)30986-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirenberg M.S., Requena L., Santonja C., Smith G.T., McClain S.A. Histopathology of Persistent Long COVID Toe: A Case Report. J. Cutan. Pathol. 2022;49:791&#x2013;794. doi: 10.1111/cup.14240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.14240</ArticleId><ArticleId IdType="pmc">PMC9111773</ArticleId><ArticleId IdType="pubmed">35366017</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Bunker C.B., Ciurtin C., Porter J.C., Chambers R.C., Papdopoulou C., Garthwaite H., Hillman T., Heightman M., Howell K.J., et al. Chilblain-like acral lesions in long COVID-19: Management and implications for understanding microangiopathy. Lancet Infect. Dis. 2021;7:912. doi: 10.1016/S1473-3099(21)00133-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00133-X</ArticleId><ArticleId IdType="pmc">PMC8221732</ArticleId><ArticleId IdType="pubmed">33705725</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., Possick J.D., Systrom D.M., Waxman A.B. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo Camaz&#xf3;n N., Teisa A., Mart&#xed;nez Membrivea M.J., Llibre C., Bay&#xe9;s-Gen&#xed;s A., Mateu L. Long COVID-19 and microvascular disease-related angina. Rev. Espa&#xf1;Ola Cardiol. 2021 doi: 10.1016/j.rec.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8552551</ArticleId><ArticleId IdType="pubmed">34824040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Persistent brainstem dysfunction in long-COVID: A hypothesis. ACS Chem. Neurosci. 2021;12:573&#x2013;580. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J., Balagny P., Arnoult F., Mangin L., Bancal C., d&#x2019;Ortho M.P., Frija-Masson J. Hyperventilation: A possible explanation for long-lasting exercise intolerance in mild Covid-19 survivors? Front. Physiol. 2021;11:1856. doi: 10.3389/fphys.2020.614590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.614590</ArticleId><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng L.N., Bonilla H.F., Shafer R.W., Miglis M.G., Yang P.C. Case Report of Breakthrough Long COVID and the Use of Nirmatrelvir-Ritonavir. Researchsquare. 2022 doi: 10.21203/rs.3.rs-1443341/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1443341/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M.A., Casado-Fern&#xe1;ndez G., Dom&#xed;nguez-Mateos S., Mateos E., Ramos-Mart&#xed;n F., Planelles V., Torres M., et al. Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers. Front. Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziporyn T.D. Nameless Diseases. Rudger Universty Press; New Brunswick, NJ, USA: 1992.</Citation></Reference><Reference><Citation>Arnold D.T., Milne A., Samms E., Stadon L., Maskell N.A., Hamilton F.W. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: A case series. Ann. Intern. Med. 2021;174:1334&#x2013;1336. doi: 10.7326/M21-1976.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1976</ArticleId><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D., Verveen A., Lebbink R., van der Straten K., Kootstra N., van Gils M.J., Russell C., et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/j.vaccine.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Leen B., Delaunois I., Carrigan M., McCarthy S. Evidence Summary: What Is the Latest Evidence about the Existence of Long-COVID or Post-COVID and Its Persistence for COVID-19 Survivors? What Evidence Is Currently Available on the Management of Patients Who Have Post Viral Fatigue Syndrome Due to COVID-19? [v1.1] 2021.  [(accessed on 1 September 2022)].  Available online:  https://doi.org/http://hdl.handle.net/10147/628919.</Citation></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:1&#x2013;17. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain O., Romano S.K., Miryala R., Tsai J., Parikh V., Umanah G.K. SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches. J. Neurosci. 2021;41:5338&#x2013;5349. doi: 10.1523/JNEUROSCI.3188-20.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3188-20.2021</ArticleId><ArticleId IdType="pmc">PMC8221594</ArticleId><ArticleId IdType="pubmed">34162747</ArticleId></ArticleIdList></Reference><Reference><Citation>Housman H.A. Exploring Neuroplasticity in the Classroom: Teaching Cortical Reorganization in the Visual System with a Stroke Patient Study.  [(accessed on 7 July 2022)];2020  Available online:  https://pubmed.ncbi.nlm.nih.gov/33880107/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040846</ArticleId><ArticleId IdType="pubmed">33880107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuut T., M&#xfc;ller F., Aldenkamp A., Assmann-Schuilwerve E., Braamse A., Geerlings S., Gibney K., Kanaan R., Nieuwkerk P., Olde Hartman T., et al. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): Study protocol. Trials. 2021;22:867. doi: 10.1186/s13063-021-05569-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05569-y</ArticleId><ArticleId IdType="pmc">PMC8637041</ArticleId><ArticleId IdType="pubmed">34857010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugazzaro S., Contri A., Esseroukh O., Kaleci S., Croci S., Massari M., Facciolongo N.C., Besutti G., Iori M., Salvarani C., et al. Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review. Int. J. Environ. Res. Public Health. 2022;19:5185. doi: 10.3390/ijerph19095185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095185</ArticleId><ArticleId IdType="pmc">PMC9104923</ArticleId><ArticleId IdType="pubmed">35564579</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamoulle M. Trajet de Soins &#xab;Long Covid&#xbb;: Comment &#xe7;a marche?&#x2014;[Long Covid Pathway, How It Works?] 2022.  [(accessed on 1 September 2022)].  Available online:  https://orbi.uliege.be/handle/2268/293637.</Citation></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021:1&#x2013;18. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzych &#x141;.J., Putowski Z., Czok M., Hofman M. What Is the Role of Therapeutic Plasma Exchange as an Adjunctive Treatment in Severe COVID-19: A Systematic Review. Viruses. 2021;13:1484. doi: 10.3390/v13081484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081484</ArticleId><ArticleId IdType="pmc">PMC8402853</ArticleId><ArticleId IdType="pubmed">34452349</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry C. Opening the Black Box: The Researchers Trying to Find Treatments for Long COVID&#x2014;The Pharmaceutical Journal. 2022.  [(accessed on 1 September 2022)].  Available online:  https://pharmaceutical-journal.com/article/feature/opening-the-black-box-the-researchers-trying-to-find-treatments-for-long-covid.</Citation></Reference><Reference><Citation>Szolnoky G., Gonz&#xe1;lez-Ochoa A.J. Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients? Clin. Appl. Thromb. 2022;28:10760296221084300. doi: 10.1177/10760296221084300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296221084300</ArticleId><ArticleId IdType="pmc">PMC8961374</ArticleId><ArticleId IdType="pubmed">35333125</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kander T. Coagulation disorder in COVID-19. Lancet Haematol. 2020;7:e630&#x2013;e632. doi: 10.1016/S2352-3026(20)30218-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30218-0</ArticleId><ArticleId IdType="pmc">PMC7351400</ArticleId><ArticleId IdType="pubmed">32659213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H.A.S., Merrell E., Ismail M., Joudeh A.I., Riley J.B., Shawkat A., Habeb H., Darling E., Goweda R.A., Shehata M.H., et al. Rationales and uncertainties for aspirin use in COVID-19: A narrative review. Fam. Med. Community Health. 2021;9:e000741. doi: 10.1136/fmch-2020-000741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fmch-2020-000741</ArticleId><ArticleId IdType="pmc">PMC8061559</ArticleId><ArticleId IdType="pubmed">33879541</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Moremi K., Oladejo S., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) can resolve their persistent symptoms. Res. Sq. 2021 doi: 10.21203/rs.3.rs-1205453/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1205453/v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>